Francesco de Rubertis

Francesco de Rubertis

56 year
Health Technology
Commercial Services
Consumer Services

Profile

Francesco de Rubertis is the founder of Medicxi Ventures (Jersey) Ltd., holding the title of Partner since 2015.
Current jobs include Chairman at Centessa Pharmaceuticals Plc since 2020, Director at Hamilton Pharmaceuticals, Inc., Director at Genebiotech Co., Ltd., Director at the University of Geneva, Non-Executive Director at Xenikos BV since 2018, Director at Egalet A, Director at Levicept Ltd., Director at Critical Pressure Ltd., Director at Rivus Pharmaceuticals, Inc., Director at Centessa Pharmaceuticals (Orexia) Ltd. since 2018, Director at Synox Therapeutics Ltd., Director at SDS Therapeutics Ltd. since 2020, Director at Ottimo Pharma Ltd., and Director at Alys Pharmaceuticals, Inc. Former jobs include Chairman at PanGenetics BV, Non-Executive Director at BioXell SpA from 2011 to 2012, Director at Cellzome Ltd., Director at ParAllele BioScience, Inc., Director at NormOxys, Inc., Director at Zyla Life Sciences LLC, Director at Genmab A, Director at CareX SA, Director at Addex Therapeutics Ltd., Director at Egalet Ltd., Director at 7TM A, Director-Executive Board at GlycoVaxyn AG in 2009, Non-Executive Director at Molecular Partners AG, Director-Investor Relations at SpinX Technologies SA, Director at UltraHuman Ltd. from 2020 to 2023, Director at Cyrenaic Pharmaceuticals, Inc., Independent Director at Versartis, Inc. in 2014, Independent Director at Minerva Neurosciences, Inc. from 2014 to 2017, Director at Inexia Ltd., Board Observer at Sequenta, Inc., Member-Supervisory Board at Profibrix BV in 2011, and Partner at Index Ventures (UK) LLP from 1998 to 2016.
Education includes an undergraduate degree from the University of Pavia and a doctorate from the University of Geneva.

Francesco de Rubertis active positions

CompaniesPositionStart
CENTESSA PHARMACEUTICALS PLC Chairman 01/11/2020
Director/Board Member -
Founder 03/11/2015
Director/Board Member 05/10/2018
Director/Board Member 18/12/2020
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -

Former positions of Francesco de Rubertis

CompaniesPositionEnd
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░ ░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Francesco de Rubertis's experience

Training of Francesco de Rubertis

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

58

1st degree connections

37

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies37

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Francesco de Rubertis
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!